Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Apr 11, 2024
Rise on Falls: Profitable Bearish Trades in Up Markets with Tickeron's Best Robot!

Rise on Falls: Profitable Bearish Trades in Up Markets with Tickeron's Best Robot!

The Tickeron quant team proudly presents our top-performing AI robot for swing traders. This robot stands out with its remarkable accuracy, empowering traders to capitalize on diverse market conditions and transaction types. Demonstrating its proficiency, it achieved profitability in short trades during last week's strong uptrend in the US stock markets. This tool is designed to be a steadfast ally for traders seeking precise, independent trading decisions, adapting seamlessly to fluctuating market dynamics.


Swing Trader, Popular Stocks: Price Action Trading Strategy (TA&FA)

 

 

 

Click to view full description and closed trades for free!

Medium-Term Price Impulse Identification

Our robot excels in detecting medium-term price impulses at the start of trends, leveraging volatility. Its algorithm skillfully navigates different market conditions, focusing on volatility and historical data to identify high-probability price movements.

Proprietary Entry Point Analysis

The robot's advanced phase involves using exclusive indicators to determine the ideal entry points. It balances medium-term and short-term trends, ensuring a nuanced approach to market entry.

Fixed Profit and Trailing Stop Strategy

Upon trade initiation, we set a fixed strong performance target and incorporate a medium-term trailing stop. This strategy enhances the precision in identifying price reversal points, balancing risk and reward effectively.

Selection of Liquid Stocks and Risk Management

We prioritize liquid, actively traded stocks in the US market, ensuring smooth trade execution. Our strategy also includes fundamental analysis to avoid stocks with potential risks like bankruptcy, ensuring a safer trading environment.
 

Set sail towards trading success with our AI Robot, crafted to revolutionize your approach in the stock market.

 

Here are the latest trades:

 

 


Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
AstraZeneca reported Q1 2026 total revenue of $15.3 billion, up 8% at constant exchange rates (CER, adjusting for currency fluctuations), beating consensus estimates around $14.8 billion. Core earnings per share (EPS) rose 5% to $2.58 at CER, amid a 12% increase in core operating profit.
Consensus estimates call for Q3 FY2026 revenue of approximately $3.37 billion, in line with the company's guidance midpoint of $3.35 billion. Non-GAAP earnings per share (EPS) expected at $9.16, edging above the guided midpoint of $9.08.